Navigation Links
Clarithromycin tablets to be launched in India soon

Ranbaxy Laboratories Limited has recently launched its approved generic formulation of clarithromycin// immediate release tablets in the US, according to a press release. Ranbaxy has been given the green signal to manufacture and market Clarithromycin tablets—250 mg and 500 mg under the Ranbaxy label. Clarithromycin tablets are indicated for the treatment of mild to moderate infections caused by susceptible strains of designated micro-organisms.

The US Food and Drug Administration (FDA), has determined that Ranbaxy’s formulation can be expected to have the same therapeutic effect as an equivalent dose of Abbott’s Biaxin Filmtab (clarithromycin tablets, USP). Jim Meehan, vice-president of Sales and Marketing for Ranbaxy Pharmaceuticals Inc (RPI) on behalf of the whole team of Ranbaxy has been stated as saying that he is very delighted to market the drug and also mentioned that they have plans to bring the product to the Indian market very soon
'"/>




Page: 1

Related medicine news :

1. Ranbaxy Launches Clarithromycin, Terbinafine Tablets in Japan
2. Cadila gets US FDA approval for Promethazine tablets
3. Say no to detox tablets
4. Manic Ecstasy: Man gets Into a Frenzy after a Record Consumption of 40,000 ecstasy tablets
5. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
6. Asmanex Twisthaler launched by Schering-Plough for treatment of asthma
7. New initiative launched to fight malaria by repelling mosquitoes
8. Guide for physicians launched to help them identify alcohol disorders
9. New X-ray machine launched by GE Healthcare
10. Historic trial for tuberculosis launched together by leading drug companies
11. New tetanus-diphtheria combination vaccine launched by Serum Institute of India
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2017)... , ... May 24, 2017 , ... ... of ExtraHop to its solutions portfolio. ExtraHop delivers an analytics-first approach, layered with ... every IT system, from the datacenter to the cloud to the edge. Through ...
(Date:5/24/2017)... ... 24, 2017 , ... The CFOs included on this list ... in the nation and help their organizations navigate the challenges in healthcare today. ... in developing successful hospital and health system strategy. , Becker's Hospital Review has ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International (MDLand), a ... today that its iClinic V12.2 solution has achieved approval from National Center for ... PCMH 2017 standards which emphasize team-based care with a significant focus on the ...
(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge, MA, May ... since 2009, according to a Workers Compensation Research Institute (WCRI) study, a contrast ... North Carolina System: CompScope™ Benchmarks, 17th Edition looks at indemnity and medical ...
(Date:5/23/2017)... ... 2017 , ... London, May 23, 2017: Walter Schindler, the Founder and Managing ... Guest Speaker and Contributor to a weeklong series of classes, meetings, field trips and ... , Walter Schindler and SAIL Capital have received an increasing number ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)... -- Bayer announced today that the latest research from across ... 53 rd Annual Meeting of the American Society ... Chicago . The ... and thyroid cancers, as well as lymphomas, and includes ... of copanlisib in patients with relapsed or refractory follicular ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: